Pilot Therapeutics
This article was originally published in The Tan Sheet
Executive Summary
Company acquires majority ownership of New York-based food distributor Interallied Group Sept. 5; will change name traded on NASDAQ OTC bulletin board to Pilot Therapeutics. Pilot plans to launch medical food Airozin - a leukotriene antagonist asthma product to be manufactured at DPT Labs in San Antonio - in first half of 2002. Radio and print ads will break approximately three months before launch, with professional campaign targeting asthma doctors and general campaign reaching the public. Saratoga Springs, N.Y.-based advertising firm Palio Communications will oversee the promotional campaign